There are four Committees operating under the Board, each with a Chairman and consisting of several Board Members and, when necessary, co-opted members of the community with a special expertise and/or interest in macular disease. All Committees have terms of reference approved by the Board and meet quarterly.
Audit and Risk Committee
The role of the Audit and Risk Committee is to oversee and enhance the credibility of the financial reporting process, external audit process, the risk management process, the internal control framework of the Foundation and review related party transactions. The Audit and Risk Committee comprises Paul Rogan (Chair), Ashley Chapman, Colonel John Fenwick, Robert Kaye, and John McCarroll.
Client Services Committee
The role of the Client Services Committee is to oversee and enhance the ability of the Foundation in providing the highest quality of service and product to meet the needs of the clients. The Client Services Committee comprises Suellen Tapsall (Chair), Ashley Chapman, Richard Grills and Imelda Lynch.
The role of the Medical Committee is to provide medical expertise, guidance and advice to the Foundation. The Medical Committee comprises Dr Jim Runciman (Chair), Dr Amanda Greaves, Dr Alex Harper, Associate Professor Wilson Heriot, Dr David Hilford, Associate Professor Alex P Hunyor, Associate Anthony Kwan, Dr Tharmalingam Mahendrarajah, Professor Paul Mitchell, Associate Professor Nitin Verma, Dr Peter van Wijngaarden and Associate Professor Dimitri Yellachich.
The role of the Research Committee is to oversee and provide guidance on the Foundation's Research Grants Program. The Research Committee comprises Associate Professor Nitin Verma (Chair), Associate Professor Tony Kwan, Imelda Lynch, Dr. Jim Runciman, Suellen Tapsall and Dr Peter van Wijngaarden.
Board Nomination and Evaluation Committee
The role of the Board Nomination and Evaluation Committee is to review Board appointments and performance. The Board Nomination and Evaluation Committee comprises Ashley Chapman and John McCarroll.